Literature DB >> 2191294

Trans-activating rev protein of the human immunodeficiency virus 1 interacts directly and specifically with its target RNA.

S Daefler1, M E Klotman, F Wong-Staal.   

Abstract

The 20-kDa phosphorylated rev protein from human immunodeficiency virus 1 has been shown to transactivate posttranscriptionally the expression of viral structural proteins by selective stabilization and nuclear export of unspliced and incompletely spliced viral mRNA. We could demonstrate in gel-mobility and immunoprecipitation assays that the recombinant rev protein purified from a baculovirus expression system forms a distinct and specific complex with its target RNA (rev-responsive element), a 234-nucleotide sequence within the envelope coding region of human immunodeficiency virus 1. No complex formation could be observed using RNAs with similar secondary structure nor with other human immunodeficiency virus 1 recombinant proteins. Deletion analysis mapped this specific binding to the first 90 nucleotides of this rev-responsive element, which contains a U2 small nuclear RNA homologous region. We propose that the specific binding of rev to its target RNA sequence plays an essential part in releasing an incompletely spliced viral mRNA containing this target sequence to the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2191294      PMCID: PMC54158          DOI: 10.1073/pnas.87.12.4571

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Mature mRNA is selectively released from the nuclear matrix by an ATP/dATP-dependent mechanism sensitive to topoisomerase inhibitors.

Authors:  H C Schröder; D Trölltsch; U Friese; M Bachmann; W E Müller
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

2.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

3.  Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.

Authors:  S Y Kao; A F Calman; P A Luciw; B M Peterlin
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

4.  Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.

Authors:  J Sodroski; R Patarca; C Rosen; F Wong-Staal; W Haseltine
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

5.  The trans-activator gene of HTLV-III is essential for virus replication.

Authors:  A G Fisher; M B Feinberg; S F Josephs; M E Harper; L M Marselle; G Reyes; M A Gonda; A Aldovini; C Debouk; R C Gallo
Journal:  Nature       Date:  1986 Mar 27-Apr 2       Impact factor: 49.962

6.  NMDA receptors trigger excitement.

Authors:  D M Barnes
Journal:  Science       Date:  1988-01-15       Impact factor: 47.728

7.  HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.

Authors:  M B Feinberg; R F Jarrett; A Aldovini; R C Gallo; F Wong-Staal
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

Review 8.  Transport of mRNA from nucleus to cytoplasm.

Authors:  H C Schröder; M Bachmann; B Diehl-Seifert; W E Müller
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1987

9.  Mg2+ induces a sharp and reversible transition in U1 and U2 small nuclear ribonucleoprotein configurations.

Authors:  I Reveillaud; M N Lelay-Taha; J Sri-Widada; C Brunel; P Jeanteur
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

10.  Expression of the art/trs protein of HIV and study of its role in viral envelope synthesis.

Authors:  D M Knight; F A Flomerfelt; J Ghrayeb
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

View more
  28 in total

Review 1.  Mechanism of action of regulatory proteins encoded by complex retroviruses.

Authors:  B R Cullen
Journal:  Microbiol Rev       Date:  1992-09

2.  Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.

Authors:  S Venkatesan; S M Gerstberger; H Park; S M Holland; Y Nam
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

3.  Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate.

Authors:  K S Cook; G J Fisk; J Hauber; N Usman; T J Daly; J R Rusche
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

4.  A specific sequence with a bulged guanosine residue(s) in a stem-bulge-stem structure of Rev-responsive element RNA is required for trans activation by human immunodeficiency virus type 1 Rev.

Authors:  S M Holland; M Chavez; S Gerstberger; S Venkatesan
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

5.  Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type I Rex protein: implications for trans dominance.

Authors:  I Weichselbraun; J Berger; M Dobrovnik; H Bogerd; R Grassmann; W C Greene; J Hauber; E Böhnlein
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  Comparative analysis of Rev function in human immunodeficiency virus types 1 and 2.

Authors:  E D Garrett; B R Cullen
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

7.  Inhibition of human immunodeficiency virus type 1 Rev-Rev-response element complex formation by complementary oligonucleotides.

Authors:  D J Chin
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

8.  Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif.

Authors:  M L Zapp; T J Hope; T G Parslow; M R Green
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

9.  Single-nucleotide changes in the HIV Rev-response element mediate resistance to compounds that inhibit Rev function.

Authors:  Deidra Shuck-Lee; Hua Chang; Emily A Sloan; Marie-Louise Hammarskjold; David Rekosh
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

10.  The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs.

Authors:  D M D'Agostino; B K Felber; J E Harrison; G N Pavlakis
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.